The World Health Organization is to unveil plans for a voluntary global patent pool for COVID-19 vaccines, medicines and diagnostics, but has been criticized by big pharma leaders before its launch.
Pfizer Chief Calls Patent Pool ‘Nonsense’, Fears Tussle Over Vaccine
Big Pharma Pledges No Profits During Pandemic, But Will Not Relinquish IP
Pharma will oppose a patent pool, but the world still needs a way to guarantee fair access to COVID-19 vaccines.
More from Business
More from Scrip
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
• By
By allowing it to enter the brain more easily, trontinemab’s brain shuttle brings more patients to ‘amyloid zero’ levels faster, and with fewer brain swelling side effects.
• By
Compass' bispecific antibody tovecimig hits primary efficacy endpoint in Phase II/III top-line data in advanced biliary tract cancer, and may have class side-effect advantages. But additional survival data may be needed to support US approval.